查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
體外診斷用乳膠粒子的全球市場:2030年為止的預測
市場調查報告書
商品編碼
1604021

體外診斷用乳膠粒子的全球市場:2030年為止的預測

Global Latex Particle for In-Vitro Diagnostics Market Insights, Forecast to 2030
出版日期: | 出版商: QYResearch | 英文 224 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球體外診斷乳膠顆粒市場規模預計將從2024年的5,102萬美元成長到2030年的7,025萬美元，預測期內複合年增長率（CAGR）為5.48%。

目前，由於技術壁壘較高，體外診斷產業乳膠顆粒市場集中度較高。主要參與者包括 JSR Life Sciences、Merck、Bangs Laboratories、Thermo Fisher 和 VDO Biotech。 JSR Life Sciences 是最大的公司，2023 年全球銷售佔有率為 47.55%。

從產品類型來看，市場主流是羧基改質乳膠顆粒，佔60%以上的市佔率。從產品應用來看，乳膠免疫比濁法是最大的應用方向，佔超過50%。

從消費來看，北美、中國、歐洲是主要消費地區，2023年累計佔全球總銷量的93.27%。

本報告提供全球體外診斷用乳膠粒子市場相關調查，提供市場概要，以及各類型，各用途，各地區的趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 調查目標範圍

  • 體外診斷用乳膠粒子的產品簡介
  • 各類型市場
  • 各用途市場
  • 前提與限制
  • 調查目的
  • 對象年

第2章 全球體外診斷用乳膠粒子的生產

  • 全球體外診斷用乳膠粒子的生產能力(2019年～2030年)
  • 全球體外診斷用乳膠粒子的生產量:2019年VS2023年VS2030年，各地區
  • 全球體外診斷用乳膠粒子的生產量，各地區
  • 美國
  • 歐洲
  • 中國
  • 日本

第3章 摘要整理

第4章 廠商間的競爭

第5章 市場規模(各類型)

  • 全球體外診斷用乳膠粒子的收益(各類型)
  • 全球體外診斷用乳膠粒子的銷售額(各類型)
  • 全球體外診斷用乳膠粒子的價格(各類型)

第6章 市場規模(各用途)

  • 全球體外診斷用乳膠粒子的收益(各用途)
  • 全球體外診斷用乳膠粒子的銷售額(各用途)
  • 全球體外診斷用乳膠粒子的價格(各用途)

第7章 美國·加拿大

第8章 歐洲

第9章 中國

第10章 亞洲(中國以外)

第11章 中東·非洲，南美

第12章 企業簡介

  • JSR Life Sciences
  • Merck
  • Bangs Laboratories
  • Thermo Fisher
  • Agilent
  • IKERLAT Polymers
  • Fujikura Kasei
  • CD Bioparticles
  • VDO Biotech
  • Suzhou NanoMicro
  • Sunresin New Materials

第13章 產業鏈和銷售管道的分析

  • 體外診斷用乳膠粒子產業鏈分析
  • 體外診斷用乳膠粒子的主要原料
  • 體外診斷用乳膠粒子的製造方式和流程
  • 體外診斷用乳膠粒子的銷售及行銷
  • 體外診斷用乳膠粒子

第14章 體外診斷用乳膠粒子市場動態

第15章 體外診斷用乳膠粒子相關世界規模調查的主要調查結果

第16章 附錄

The global Latex Particle for In-Vitro Diagnostics market is projected to grow from US$ 51.02 million in 2024 to US$ 70.25 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.48% during the forecast period.

At present, the market concentration of the latex particle for IVD industry is relatively high due to the high technology barrier. Key players include JSR Life Sciences, Merck, Bangs Laboratories, Thermo Fisher, VDO Biotech and so on. JSR Life Sciences is the largest player, accounting for 47.55% revenue share globally in 2023.

In terms of product types, the mainstream product on the market is carboxy-modified latex particles, which occupies more than 60% of the market share. As for product applications, latex immunoturbidimetry is the largest application direction, accounting for more than 50%.

For consumption, North America, China and Europe are the main consumption areas, cumulatively accounting for 93.27% of the global total sales in 2023.

In terms of production side, this report researches the Latex Particle for In-Vitro Diagnostics production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.

In terms of consumption side, this report focuses on the sales of Latex Particle for In-Vitro Diagnostics by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.

Report Includes:

This report presents an overview of global market for Latex Particle for In-Vitro Diagnostics, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Latex Particle for In-Vitro Diagnostics, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Latex Particle for In-Vitro Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Latex Particle for In-Vitro Diagnostics sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Latex Particle for In-Vitro Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Latex Particle for In-Vitro Diagnostics sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including JSR Life Sciences, Merck, Bangs Laboratories, Thermo Fisher, Agilent, IKERLAT Polymers, Fujikura Kasei, CD Bioparticles, and VDO Biotech, etc.

Market Segmentation

By Company

  • JSR Life Sciences
  • Merck
  • Bangs Laboratories
  • Thermo Fisher
  • Agilent
  • IKERLAT Polymers
  • Fujikura Kasei
  • CD Bioparticles
  • VDO Biotech
  • Suzhou NanoMicro
  • Sunresin New Materials

Segment by Type

  • Plain Latex Particles
  • Carboxy-Modified Latex Particles
  • Other

Segment by Application

  • Latex Immunoturbidimetry
  • Latex Agglutination Test
  • Immunochromatography
  • Other

Production by Region

  • North America
  • Europe
  • China
  • Japan

Sales by Region

US & Canada

  • U.S.
  • Canada

China

Asia (excluding China)

  • Japan
  • South Korea
  • China Taiwan
  • Southeast Asia
  • India Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia

Middle East, Africa, Latin America

  • Brazil
  • Mexico
  • Turkey
  • GCC Countries

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Latex Particle for In-Vitro Diagnostics production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 3: Sales (consumption), revenue of Latex Particle for In-Vitro Diagnostics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Latex Particle for In-Vitro Diagnostics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 9: China by Type, and by Application, sales, and revenue for each segment.

Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Latex Particle for In-Vitro Diagnostics sales, revenue, price, gross margin, and recent development, etc.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 15: The main points and conclusions of the report.

Table of Contents

1 Study Coverage

  • 1.1 Latex Particle for In-Vitro Diagnostics Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Latex Particle for In-Vitro Diagnostics Market Size by Type, 2019 VS 2023 VS 2030
    • 1.2.2 Plain Latex Particles
    • 1.2.3 Carboxy-Modified Latex Particles
    • 1.2.4 Other
  • 1.3 Market by Application
    • 1.3.1 Global Latex Particle for In-Vitro Diagnostics Market Size by Application, 2019 VS 2023 VS 2030
    • 1.3.2 Latex Immunoturbidimetry
    • 1.3.3 Latex Agglutination Test
    • 1.3.4 Immunochromatography
    • 1.3.5 Other
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Latex Particle for In-Vitro Diagnostics Production

  • 2.1 Global Latex Particle for In-Vitro Diagnostics Production Capacity (2019-2030)
  • 2.2 Global Latex Particle for In-Vitro Diagnostics Production by Region: 2019 VS 2023 VS 2030
  • 2.3 Global Latex Particle for In-Vitro Diagnostics Production by Region
    • 2.3.1 Global Latex Particle for In-Vitro Diagnostics Historic Production by Region (2019-2024)
    • 2.3.2 Global Latex Particle for In-Vitro Diagnostics Forecasted Production by Region (2025-2030)
    • 2.3.3 Global Latex Particle for In-Vitro Diagnostics Production Market Share by Region (2019-2030)
  • 2.4 USA
  • 2.5 Europe
  • 2.6 China
  • 2.7 Japan

3 Executive Summary

  • 3.1 Global Latex Particle for In-Vitro Diagnostics Revenue Estimates and Forecasts 2019-2030
  • 3.2 Global Latex Particle for In-Vitro Diagnostics Revenue by Region
    • 3.2.1 Global Latex Particle for In-Vitro Diagnostics Revenue by Region: 2019 VS 2023 VS 2030
    • 3.2.2 Global Latex Particle for In-Vitro Diagnostics Revenue by Region (2019-2024)
    • 3.2.3 Global Latex Particle for In-Vitro Diagnostics Revenue by Region (2025-2030)
    • 3.2.4 Global Latex Particle for In-Vitro Diagnostics Revenue Market Share by Region (2019-2030)
  • 3.3 Global Latex Particle for In-Vitro Diagnostics Sales Estimates and Forecasts 2019-2030
  • 3.4 Global Latex Particle for In-Vitro Diagnostics Sales by Region
    • 3.4.1 Global Latex Particle for In-Vitro Diagnostics Sales by Region: 2019 VS 2023 VS 2030
    • 3.4.2 Global Latex Particle for In-Vitro Diagnostics Sales by Region (2019-2024)
    • 3.4.3 Global Latex Particle for In-Vitro Diagnostics Sales by Region (2025-2030)
    • 3.4.4 Global Latex Particle for In-Vitro Diagnostics Sales Market Share by Region (2019-2030)
  • 3.5 US & Canada
  • 3.6 Europe
  • 3.7 China
  • 3.8 Asia (excluding China)
  • 3.9 Middle East, Africa and Latin America

4 Competition by Manufacturers

  • 4.1 Global Latex Particle for In-Vitro Diagnostics Sales by Manufacturers
    • 4.1.1 Global Latex Particle for In-Vitro Diagnostics Sales by Manufacturers (2019-2024)
    • 4.1.2 Global Latex Particle for In-Vitro Diagnostics Sales Market Share by Manufacturers (2019-2024)
    • 4.1.3 Global Top 3 and Top 5 Largest Manufacturers of Latex Particle for In-Vitro Diagnostics in 2023
  • 4.2 Global Latex Particle for In-Vitro Diagnostics Revenue by Manufacturers
    • 4.2.1 Global Latex Particle for In-Vitro Diagnostics Revenue by Manufacturers (2019-2024)
    • 4.2.2 Global Latex Particle for In-Vitro Diagnostics Revenue Market Share by Manufacturers (2019-2024)
    • 4.2.3 Global Top 3 and Top 5 Companies by Latex Particle for In-Vitro Diagnostics Revenue in 2023
  • 4.3 Global Latex Particle for In-Vitro Diagnostics Sales Price by Manufacturers (2019-2024)
  • 4.4 Global Key Players of Latex Particle for In-Vitro Diagnostics, Industry Ranking, 2022 VS 2023
  • 4.5 Analysis of Competitive Landscape
    • 4.5.1 Manufacturers Market Concentration Ratio (CR5)
    • 4.5.2 Global Latex Particle for In-Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 4.6 Global Key Manufacturers of Latex Particle for In-Vitro Diagnostics, Manufacturing Base Distribution and Headquarters
  • 4.7 Global Key Manufacturers of Latex Particle for In-Vitro Diagnostics, Product Offered and Application
  • 4.8 Establish Date of Global Key Manufacturers of Latex Particle for In-Vitro Diagnostics
  • 4.9 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type

  • 5.1 Global Latex Particle for In-Vitro Diagnostics Sales by Type
    • 5.1.1 Global Latex Particle for In-Vitro Diagnostics Historical Sales by Type (2019-2024)
    • 5.1.2 Global Latex Particle for In-Vitro Diagnostics Forecasted Sales by Type (2025-2030)
    • 5.1.3 Global Latex Particle for In-Vitro Diagnostics Sales Market Share by Type (2019-2030)
  • 5.2 Global Latex Particle for In-Vitro Diagnostics Revenue by Type
    • 5.2.1 Global Latex Particle for In-Vitro Diagnostics Historical Revenue by Type (2019-2024)
    • 5.2.2 Global Latex Particle for In-Vitro Diagnostics Forecasted Revenue by Type (2025-2030)
    • 5.2.3 Global Latex Particle for In-Vitro Diagnostics Revenue Market Share by Type (2019-2030)
  • 5.3 Global Latex Particle for In-Vitro Diagnostics Price by Type
    • 5.3.1 Global Latex Particle for In-Vitro Diagnostics Price by Type (2019-2024)
    • 5.3.2 Global Latex Particle for In-Vitro Diagnostics Price Forecast by Type (2025-2030)

6 Market Size by Application

  • 6.1 Global Latex Particle for In-Vitro Diagnostics Sales by Application
    • 6.1.1 Global Latex Particle for In-Vitro Diagnostics Historical Sales by Application (2019-2024)
    • 6.1.2 Global Latex Particle for In-Vitro Diagnostics Forecasted Sales by Application (2025-2030)
    • 6.1.3 Global Latex Particle for In-Vitro Diagnostics Sales Market Share by Application (2019-2030)
  • 6.2 Global Latex Particle for In-Vitro Diagnostics Revenue by Application
    • 6.2.1 Global Latex Particle for In-Vitro Diagnostics Historical Revenue by Application (2019-2024)
    • 6.2.2 Global Latex Particle for In-Vitro Diagnostics Forecasted Revenue by Application (2025-2030)
    • 6.2.3 Global Latex Particle for In-Vitro Diagnostics Revenue Market Share by Application (2019-2030)
  • 6.3 Global Latex Particle for In-Vitro Diagnostics Price by Application
    • 6.3.1 Global Latex Particle for In-Vitro Diagnostics Price by Application (2019-2024)
    • 6.3.2 Global Latex Particle for In-Vitro Diagnostics Price Forecast by Application (2025-2030)

7 US & Canada

  • 7.1 US & Canada Latex Particle for In-Vitro Diagnostics Market Size by Type
    • 7.1.1 US & Canada Latex Particle for In-Vitro Diagnostics Sales by Type (2019-2030)
    • 7.1.2 US & Canada Latex Particle for In-Vitro Diagnostics Revenue by Type (2019-2030)
  • 7.2 US & Canada Latex Particle for In-Vitro Diagnostics Market Size by Application
    • 7.2.1 US & Canada Latex Particle for In-Vitro Diagnostics Sales by Application (2019-2030)
    • 7.2.2 US & Canada Latex Particle for In-Vitro Diagnostics Revenue by Application (2019-2030)
  • 7.3 US & Canada Latex Particle for In-Vitro Diagnostics Market Size by Country
    • 7.3.1 US & Canada Latex Particle for In-Vitro Diagnostics Revenue by Country: 2019 VS 2023 VS 2030
    • 7.3.2 US & Canada Latex Particle for In-Vitro Diagnostics Revenue by Country (2019-2030)
    • 7.3.3 US & Canada Latex Particle for In-Vitro Diagnostics Sales by Country (2019-2030)
    • 7.3.4 US
    • 7.3.5 Canada

8 Europe

  • 8.1 Europe Latex Particle for In-Vitro Diagnostics Market Size by Type
    • 8.1.1 Europe Latex Particle for In-Vitro Diagnostics Sales by Type (2019-2030)
    • 8.1.2 Europe Latex Particle for In-Vitro Diagnostics Revenue by Type (2019-2030)
  • 8.2 Europe Latex Particle for In-Vitro Diagnostics Market Size by Application
    • 8.2.1 Europe Latex Particle for In-Vitro Diagnostics Sales by Application (2019-2030)
    • 8.2.2 Europe Latex Particle for In-Vitro Diagnostics Revenue by Application (2019-2030)
  • 8.3 Europe Latex Particle for In-Vitro Diagnostics Market Size by Country
    • 8.3.1 Europe Latex Particle for In-Vitro Diagnostics Revenue by Country: 2019 VS 2023 VS 2030
    • 8.3.2 Europe Latex Particle for In-Vitro Diagnostics Sales by Country (2019-2030)
    • 8.3.3 Europe Latex Particle for In-Vitro Diagnostics Revenue by Country (2019-2030)
    • 8.3.4 Germany
    • 8.3.5 France
    • 8.3.6 U.K.
    • 8.3.7 Italy
    • 8.3.8 Russia

9 China

  • 9.1 China Latex Particle for In-Vitro Diagnostics Market Size by Type
    • 9.1.1 China Latex Particle for In-Vitro Diagnostics Sales by Type (2019-2030)
    • 9.1.2 China Latex Particle for In-Vitro Diagnostics Revenue by Type (2019-2030)
  • 9.2 China Latex Particle for In-Vitro Diagnostics Market Size by Application
    • 9.2.1 China Latex Particle for In-Vitro Diagnostics Sales by Application (2019-2030)
    • 9.2.2 China Latex Particle for In-Vitro Diagnostics Revenue by Application (2019-2030)

10 Asia (excluding China)

  • 10.1 Asia Latex Particle for In-Vitro Diagnostics Market Size by Type
    • 10.1.1 Asia Latex Particle for In-Vitro Diagnostics Sales by Type (2019-2030)
    • 10.1.2 Asia Latex Particle for In-Vitro Diagnostics Revenue by Type (2019-2030)
  • 10.2 Asia Latex Particle for In-Vitro Diagnostics Market Size by Application
    • 10.2.1 Asia Latex Particle for In-Vitro Diagnostics Sales by Application (2019-2030)
    • 10.2.2 Asia Latex Particle for In-Vitro Diagnostics Revenue by Application (2019-2030)
  • 10.3 Asia Latex Particle for In-Vitro Diagnostics Market Size by Region
    • 10.3.1 Asia Latex Particle for In-Vitro Diagnostics Revenue by Region: 2019 VS 2023 VS 2030
    • 10.3.2 Asia Latex Particle for In-Vitro Diagnostics Revenue by Region (2019-2030)
    • 10.3.3 Asia Latex Particle for In-Vitro Diagnostics Sales by Region (2019-2030)
    • 10.3.4 Japan
    • 10.3.5 South Korea
    • 10.3.6 China Taiwan
    • 10.3.7 Southeast Asia
    • 10.3.8 India

11 Middle East, Africa and Latin America

  • 11.1 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Market Size by Type
    • 11.1.1 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Sales by Type (2019-2030)
    • 11.1.2 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Revenue by Type (2019-2030)
  • 11.2 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Market Size by Application
    • 11.2.1 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Sales by Application (2019-2030)
    • 11.2.2 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Revenue by Application (2019-2030)
  • 11.3 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Market Size by Country
    • 11.3.1 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Revenue by Country: 2019 VS 2023 VS 2030
    • 11.3.2 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Revenue by Country (2019-2030)
    • 11.3.3 Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Sales by Country (2019-2030)
    • 11.3.4 Brazil
    • 11.3.5 Mexico
    • 11.3.6 Turkey
    • 11.3.7 GCC Countries

12 Corporate Profile

  • 12.1 JSR Life Sciences
    • 12.1.1 JSR Life Sciences Corporation Information
    • 12.1.2 JSR Life Sciences Overview
    • 12.1.3 JSR Life Sciences Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
    • 12.1.4 JSR Life Sciences Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.1.5 JSR Life Sciences Recent Developments
  • 12.2 Merck
    • 12.2.1 Merck Company Information
    • 12.2.2 Merck Overview
    • 12.2.3 Merck Latex Particle for In-Vitro Diagnostics Sales, Price, Revenue and Gross Margin (2019-2024)
    • 12.2.4 Merck Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.2.5 Merck Recent Developments
  • 12.3 Bangs Laboratories
    • 12.3.1 Bangs Laboratories Corporation Information
    • 12.3.2 Bangs Laboratories Overview
    • 12.3.3 Bangs Laboratories Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
    • 12.3.4 Bangs Laboratories Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.3.5 Bangs Laboratories Recent Developments
  • 12.4 Thermo Fisher
    • 12.4.1 Thermo Fisher Corporation Information
    • 12.4.2 Thermo Fisher Overview
    • 12.4.3 Thermo Fisher Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
    • 12.4.4 Thermo Fisher Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.4.5 Thermo Fisher Recent Developments
  • 12.5 Agilent
    • 12.5.1 Agilent Corporation Information
    • 12.5.2 Agilent Overview
    • 12.5.3 Agilent Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
    • 12.5.4 Agilent Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.5.5 Agilent Recent Developments
  • 12.6 IKERLAT Polymers
    • 12.6.1 IKERLAT Polymers Corporation Information
    • 12.6.2 IKERLAT Polymers Overview
    • 12.6.3 IKERLAT Polymers Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
    • 12.6.4 IKERLAT Polymers Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.6.5 IKERLAT Polymers Recent Developments
  • 12.7 Fujikura Kasei
    • 12.7.1 Fujikura Kasei Corporation Information
    • 12.7.2 Fujikura Kasei Overview
    • 12.7.3 Fujikura Kasei Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
    • 12.7.4 Fujikura Kasei Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.8 CD Bioparticles
    • 12.8.1 CD Bioparticles Corporation Information
    • 12.8.2 CD Bioparticles Overview
    • 12.8.3 CD Bioparticles Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
    • 12.8.4 CD Bioparticles Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.8.5 CD Bioparticles Recent Developments
  • 12.9 VDO Biotech
    • 12.9.1 VDO Biotech Corporation Information
    • 12.9.2 VDO Biotech Overview
    • 12.9.3 VDO Biotech Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
    • 12.9.4 VDO Biotech Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.9.5 VDO Biotech Recent Developments
  • 12.10 Suzhou NanoMicro
    • 12.10.1 Suzhou NanoMicro Corporation Information
    • 12.10.2 Suzhou NanoMicro Overview
    • 12.10.3 Suzhou NanoMicro Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
    • 12.10.4 Suzhou NanoMicro Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.10.5 Suzhou NanoMicro Recent Developments
  • 12.11 Sunresin New Materials
    • 12.11.1 Sunresin New Materials Corporation Information
    • 12.11.2 Sunresin New Materials Overview
    • 12.11.3 Sunresin New Materials Latex Particle for In-Vitro Diagnostics Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
    • 12.11.4 Sunresin New Materials Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications

13 Industry Chain and Sales Channels Analysis

  • 13.1 Latex Particle for In-Vitro Diagnostics Industry Chain Analysis
  • 13.2 Latex Particle for In-Vitro Diagnostics Key Raw Materials
    • 13.2.1 Key Raw Materials
    • 13.2.2 Raw Materials Key Suppliers
  • 13.3 Latex Particle for In-Vitro Diagnostics Production Mode & Process
  • 13.4 Latex Particle for In-Vitro Diagnostics Sales and Marketing
    • 13.4.1 Latex Particle for In-Vitro Diagnostics Sales Channels
    • 13.4.2 Latex Particle for In-Vitro Diagnostics Distributors
  • 13.5 Latex Particle for In-Vitro Diagnostics Customers

14 Latex Particle for In-Vitro Diagnostics Market Dynamics

    • 14.1.1 Latex Particle for In-Vitro Diagnostics Industry Trends
    • 14.1.2 Latex Particle for In-Vitro Diagnostics Market Drivers
    • 14.1.3 Latex Particle for In-Vitro Diagnostics Market Challenges
    • 14.1.4 Latex Particle for In-Vitro Diagnostics Market Restraints

15 Key Findings in the Global Latex Particle for In-Vitro Diagnostics Study

16 Appendix

  • 16.1 Research Methodology
    • 16.1.1 Methodology/Research Approach
    • 16.1.2 Data Source
  • 16.2 Author Details 195

List of Tables

  • Table 1. Global Latex Particle for In-Vitro Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
  • Table 2. Major Manufacturers of Carboxy-Modified Latex Particles
  • Table 3. Global Latex Particle for In-Vitro Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
  • Table 4. Global Latex Particle for In-Vitro Diagnostics Production Growth Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (L)
  • Table 5. Global Latex Particle for In-Vitro Diagnostics Production by Region (2019-2024) & (L)
  • Table 6. Global Latex Particle for In-Vitro Diagnostics Production by Region (2025-2030) & (L)
  • Table 7. Global Latex Particle for In-Vitro Diagnostics Production Market Share by Region (2019-2024)
  • Table 8. Global Latex Particle for In-Vitro Diagnostics Production Market Share by Region (2025-2030)
  • Table 9. Global Latex Particle for In-Vitro Diagnostics Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 10. Global Latex Particle for In-Vitro Diagnostics Revenue by Region (2019-2024) & (US$ Million)
  • Table 11. Global Latex Particle for In-Vitro Diagnostics Revenue by Region (2025-2030) & (US$ Million)
  • Table 12. Global Latex Particle for In-Vitro Diagnostics Revenue Market Share by Region (2019-2024)
  • Table 13. Global Latex Particle for In-Vitro Diagnostics Revenue Market Share by Region (2025-2030)
  • Table 14. Global Latex Particle for In-Vitro Diagnostics Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (L)
  • Table 15. Global Latex Particle for In-Vitro Diagnostics Sales by Region (2019-2024) & (L)
  • Table 16. Global Latex Particle for In-Vitro Diagnostics Sales by Region (2025-2030) & (L)
  • Table 17. Global Latex Particle for In-Vitro Diagnostics Sales Market Share by Region (2019-2024)
  • Table 18. Global Latex Particle for In-Vitro Diagnostics Sales Market Share by Region (2025-2030)
  • Table 19. Global Latex Particle for In-Vitro Diagnostics Sales by Manufacturers (2019-2024) & (L)
  • Table 20. Global Latex Particle for In-Vitro Diagnostics Sales Share by Manufacturers (2019-2024)
  • Table 21. Global Latex Particle for In-Vitro Diagnostics Revenue by Manufacturers (2019-2024) & (US$ Million)
  • Table 22. Global Latex Particle for In-Vitro Diagnostics Revenue Market Share by Manufacturers (2019-2024)
  • Table 23. Latex Particle for In-Vitro Diagnostics Price by Manufacturers (2019-2024) & (US$/Liter)
  • Table 24. Global Key Players of Latex Particle for In-Vitro Diagnostics, Industry Ranking, 2022 VS 2023
  • Table 25. Global Latex Particle for In-Vitro Diagnostics Manufacturers Market Concentration Ratio (CR5)
  • Table 26. Global Latex Particle for In-Vitro Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latex Particle for In-Vitro Diagnostics as of 2023)
  • Table 27. Global Key Manufacturers of Latex Particle for In-Vitro Diagnostics, Manufacturing Base Distribution and Headquarters
  • Table 28. Global Key Manufacturers of Latex Particle for In-Vitro Diagnostics, Product Offered and Application
  • Table 29. Establish Date of Global Key Manufacturers of Latex Particle for In-Vitro Diagnostics
  • Table 30. Mergers & Acquisitions, Expansion Plans
  • Table 31. Global Latex Particle for In-Vitro Diagnostics Sales by Type (2019-2024) & (L)
  • Table 32. Global Latex Particle for In-Vitro Diagnostics Sales by Type (2025-2030) & (L)
  • Table 33. Global Latex Particle for In-Vitro Diagnostics Sales Share by Type (2019-2024)
  • Table 34. Global Latex Particle for In-Vitro Diagnostics Sales Share by Type (2025-2030)
  • Table 35. Global Latex Particle for In-Vitro Diagnostics Revenue by Type (2019-2024) & (US$ Million)
  • Table 36. Global Latex Particle for In-Vitro Diagnostics Revenue by Type (2025-2030) & (US$ Million)
  • Table 37. Global Latex Particle for In-Vitro Diagnostics Revenue Share by Type (2019-2024)
  • Table 38. Global Latex Particle for In-Vitro Diagnostics Revenue Share by Type (2025-2030)
  • Table 39. Latex Particle for In-Vitro Diagnostics Price by Type (2019-2024) & (US$/Liter)
  • Table 40. Global Latex Particle for In-Vitro Diagnostics Price Forecast by Type (2025-2030) & (US$/Liter)
  • Table 41. Global Latex Particle for In-Vitro Diagnostics Sales by Application (2019-2024) & (L)
  • Table 42. Global Latex Particle for In-Vitro Diagnostics Sales by Application (2025-2030) & (L)
  • Table 43. Global Latex Particle for In-Vitro Diagnostics Sales Share by Application (2019-2024)
  • Table 44. Global Latex Particle for In-Vitro Diagnostics Sales Share by Application (2025-2030)
  • Table 45. Global Latex Particle for In-Vitro Diagnostics Revenue by Application (2019-2024) & (US$ Million)
  • Table 46. Global Latex Particle for In-Vitro Diagnostics Revenue by Application (2025-2030) & (US$ Million)
  • Table 47. Global Latex Particle for In-Vitro Diagnostics Revenue Share by Application (2019-2024)
  • Table 48. Global Latex Particle for In-Vitro Diagnostics Revenue Share by Application (2025-2030)
  • Table 49. Latex Particle for In-Vitro Diagnostics Price by Application (2019-2024) & (US$/Liter)
  • Table 50. Global Latex Particle for In-Vitro Diagnostics Price Forecast by Application (2025-2030) & (US$/Liter)
  • Table 51. US & Canada Latex Particle for In-Vitro Diagnostics Sales by Type (2019-2024) & (L)
  • Table 52. US & Canada Latex Particle for In-Vitro Diagnostics Sales by Type (2025-2030) & (L)
  • Table 53. US & Canada Latex Particle for In-Vitro Diagnostics Revenue by Type (2019-2024) & (US$ Million)
  • Table 54. US & Canada Latex Particle for In-Vitro Diagnostics Revenue by Type (2025-2030) & (US$ Million)
  • Table 55. US & Canada Latex Particle for In-Vitro Diagnostics Sales by Application (2019-2024) & (L)
  • Table 56. US & Canada Latex Particle for In-Vitro Diagnostics Sales by Application (2025-2030) & (L)
  • Table 57. US & Canada Latex Particle for In-Vitro Diagnostics Revenue by Application (2019-2024) & (US$ Million)
  • Table 58. US & Canada Latex Particle for In-Vitro Diagnostics Revenue by Application (2025-2030) & (US$ Million)
  • Table 59. US & Canada Latex Particle for In-Vitro Diagnostics Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 60. US & Canada Latex Particle for In-Vitro Diagnostics Revenue by Country (2019-2024) & (US$ Million)
  • Table 61. US & Canada Latex Particle for In-Vitro Diagnostics Revenue by Country (2025-2030) & (US$ Million)
  • Table 62. US & Canada Latex Particle for In-Vitro Diagnostics Sales by Country (2019-2024) & (L)
  • Table 63. US & Canada Latex Particle for In-Vitro Diagnostics Sales by Country (2025-2030) & (L)
  • Table 64. Europe Latex Particle for In-Vitro Diagnostics Sales by Type (2019-2024) & (L)
  • Table 65. Europe Latex Particle for In-Vitro Diagnostics Sales by Type (2025-2030) & (L)
  • Table 66. Europe Latex Particle for In-Vitro Diagnostics Revenue by Type (2019-2024) & (US$ Million)
  • Table 67. Europe Latex Particle for In-Vitro Diagnostics Revenue by Type (2025-2030) & (US$ Million)
  • Table 68. Europe Latex Particle for In-Vitro Diagnostics Sales by Application (2019-2024) & (L)
  • Table 69. Europe Latex Particle for In-Vitro Diagnostics Sales by Application (2025-2030) & (L)
  • Table 70. Europe Latex Particle for In-Vitro Diagnostics Revenue by Application (2019-2024) & (US$ Million)
  • Table 71. Europe Latex Particle for In-Vitro Diagnostics Revenue by Application (2025-2030) & (US$ Million)
  • Table 72. Europe Latex Particle for In-Vitro Diagnostics Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 73. Europe Latex Particle for In-Vitro Diagnostics Sales by Country (2019-2024) & (L)
  • Table 74. Europe Latex Particle for In-Vitro Diagnostics Sales by Country (2025-2030) & (L)
  • Table 75. Europe Latex Particle for In-Vitro Diagnostics Revenue by Country (2019-2024) & (US$ Million)
  • Table 76. Europe Latex Particle for In-Vitro Diagnostics Revenue by Country (2025-2030) & (US$ Million)
  • Table 77. China Latex Particle for In-Vitro Diagnostics Sales by Type (2019-2024) & (L)
  • Table 78. China Latex Particle for In-Vitro Diagnostics Sales by Type (2025-2030) & (L)
  • Table 79. China Latex Particle for In-Vitro Diagnostics Revenue by Type (2019-2024) & (US$ Million)
  • Table 80. China Latex Particle for In-Vitro Diagnostics Revenue by Type (2025-2030) & (US$ Million)
  • Table 81. China Latex Particle for In-Vitro Diagnostics Sales by Application (2019-2024) & (L)
  • Table 82. China Latex Particle for In-Vitro Diagnostics Sales by Application (2025-2030) & (L)
  • Table 83. China Latex Particle for In-Vitro Diagnostics Revenue by Application (2019-2024) & (US$ Million)
  • Table 84. China Latex Particle for In-Vitro Diagnostics Revenue by Application (2025-2030) & (US$ Million)
  • Table 85. Asia Latex Particle for In-Vitro Diagnostics Sales by Type (2019-2024) & (L)
  • Table 86. Asia Latex Particle for In-Vitro Diagnostics Sales by Type (2025-2030) & (L)
  • Table 87. Asia Latex Particle for In-Vitro Diagnostics Revenue by Type (2019-2024) & (US$ Million)
  • Table 88. Asia Latex Particle for In-Vitro Diagnostics Revenue by Type (2025-2030) & (US$ Million)
  • Table 89. Asia Latex Particle for In-Vitro Diagnostics Sales by Application (2019-2024) & (L)
  • Table 90. Asia Latex Particle for In-Vitro Diagnostics Sales by Application (2025-2030) & (L)
  • Table 91. Asia Latex Particle for In-Vitro Diagnostics Revenue by Application (2019-2024) & (US$ Million)
  • Table 92. Asia Latex Particle for In-Vitro Diagnostics Revenue by Application (2025-2030) & (US$ Million)
  • Table 93. Asia Latex Particle for In-Vitro Diagnostics Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 94. Asia Latex Particle for In-Vitro Diagnostics Revenue by Region (2019-2024) & (US$ Million)
  • Table 95. Asia Latex Particle for In-Vitro Diagnostics Revenue by Region (2025-2030) & (US$ Million)
  • Table 96. Asia Latex Particle for In-Vitro Diagnostics Sales by Region (2019-2024) & (L)
  • Table 97. Asia Latex Particle for In-Vitro Diagnostics Sales by Region (2025-2030) & (L)
  • Table 98. Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Sales by Type (2019-2024) & (L)
  • Table 99. Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Sales by Type (2025-2030) & (L)
  • Table 100. Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Revenue by Type (2019-2024) & (US$ Million)
  • Table 101. Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Revenue by Type (2025-2030) & (US$ Million)
  • Table 102. Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Sales by Application (2019-2024) & (L)
  • Table 103. Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Sales by Application (2025-2030) & (L)
  • Table 104. Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Revenue by Application (2019-2024) & (US$ Million)
  • Table 105. Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Revenue by Application (2025-2030) & (US$ Million)
  • Table 106. Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 107. Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Revenue by Country (2019-2024) & (US$ Million)
  • Table 108. Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Revenue by Country (2025-2030) & (US$ Million)
  • Table 109. Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Sales by Country (2019-2024) & (L)
  • Table 110. Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Sales by Country (2025-2030) & (L)
  • Table 111. JSR Life Sciences Corporation Information
  • Table 112. JSR Life Sciences Description and Major Businesses
  • Table 113. JSR Life Sciences Latex Particle for In-Vitro Diagnostics Capacity, Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
  • Table 114. JSR Life Sciences Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 115. JSR Life Sciences Recent Developments
  • Table 116. Merck Company Information
  • Table 117. Merck Description and Major Businesses
  • Table 118. Merck Latex Particle for In-Vitro Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
  • Table 119. Merck Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 120. Merck Recent Developments
  • Table 121. Bangs Laboratories Corporation Information
  • Table 122. Bangs Laboratories Description and Major Businesses
  • Table 123. Bangs Laboratories Latex Particle for In-Vitro Diagnostics Capacity, Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
  • Table 124. Bangs Laboratories Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 125. Bangs Laboratories Recent Developments
  • Table 126. Thermo Fisher Corporation Information
  • Table 127. Thermo Fisher Description and Major Businesses
  • Table 128. Thermo Fisher Latex Particle for In-Vitro Diagnostics Capacity, Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
  • Table 129. Thermo Fisher Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 130. Thermo Fisher Recent Developments
  • Table 131. Agilent Corporation Information
  • Table 132. Agilent Description and Major Businesses
  • Table 133. Agilent Latex Particle for In-Vitro Diagnostics Capacity, Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
  • Table 134. Agilent Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 135. Agilent Recent Developments
  • Table 136. IKERLAT Polymers Corporation Information
  • Table 137. IKERLAT Polymers Description and Major Businesses
  • Table 138. IKERLAT Polymers Latex Particle for In-Vitro Diagnostics Capacity, Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
  • Table 139. IKERLAT Polymers Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 140. IKERLAT Polymers Recent Developments
  • Table 141. Fujikura Kasei Corporation Information
  • Table 142. Fujikura Kasei Description and Major Businesses
  • Table 143. Fujikura Kasei Latex Particle for In-Vitro Diagnostics Capacity, Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
  • Table 144. Fujikura Kasei Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 145. CD Bioparticles Corporation Information
  • Table 146. CD Bioparticles Description and Major Businesses
  • Table 147. CD Bioparticles Latex Particle for In-Vitro Diagnostics Capacity, Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
  • Table 148. CD Bioparticles Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 149. CD Bioparticles Recent Developments
  • Table 150. VDO Biotech Corporation Information
  • Table 151. VDO Biotech Description and Major Businesses
  • Table 152. VDO Biotech Latex Particle for In-Vitro Diagnostics Capacity, Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
  • Table 153. VDO Biotech Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 154. VDO Biotech Recent Developments
  • Table 155. Suzhou NanoMicro Corporation Information
  • Table 156. Suzhou NanoMicro Description and Major Businesses
  • Table 157. Suzhou NanoMicro Latex Particle for In-Vitro Diagnostics Capacity, Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
  • Table 158. Suzhou NanoMicro Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 159. Suzhou NanoMicro Recent Developments
  • Table 160. Sunresin New Materials Corporation Information
  • Table 161. Sunresin New Materials Description and Major Businesses
  • Table 162. Sunresin New Materials Latex Particle for In-Vitro Diagnostics Capacity, Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
  • Table 163. Sunresin New Materials Latex Particle for In-Vitro Diagnostics Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 164. Raw Materials Key Suppliers Lists
  • Table 165. Latex Particle for In-Vitro Diagnostics Distributors List
  • Table 166. Latex Particle for In-Vitro Diagnostics Customers List
  • Table 167. Latex Particle for In-Vitro Diagnostics Market Trends
  • Table 168. Latex Particle for In-Vitro Diagnostics Market Drivers
  • Table 169. Latex Particle for In-Vitro Diagnostics Market Challenges
  • Table 170. Latex Particle for In-Vitro Diagnostics Market Restraints
  • Table 171. Research Programs/Design for This Report
  • Table 172. Key Data Information from Secondary Sources
  • Table 173. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Latex Particle for In-Vitro Diagnostics Product Picture
  • Figure 2. Global Latex Particle for In-Vitro Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
  • Figure 3. Global Latex Particle for In-Vitro Diagnostics Revenue Market Share by Type: 2023 & 2030
  • Figure 4. Major Manufacturers of Plain Latex Particles
  • Figure 5. Global Latex Particle for In-Vitro Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
  • Figure 6. Global Latex Particle for In-Vitro Diagnostics Market Share by Application in 2024 & 2030
  • Figure 7. Latex Particle for In-Vitro Diagnostics Report Years Considered
  • Figure 8. Global Latex Particle for In-Vitro Diagnostics Capacity, Production and Utilization (2019-2030) & (L)
  • Figure 9. Global Latex Particle for In-Vitro Diagnostics Production by Region: 2019 VS 2023 VS 2030 (L)
  • Figure 10. Global Latex Particle for In-Vitro Diagnostics Production Market Share by Region in Percentage: 2023 Versus 2030
  • Figure 11. Latex Particle for In-Vitro Diagnostics Production Growth Rate in USA (2019-2030) & (L)
  • Figure 12. Latex Particle for In-Vitro Diagnostics Production Growth Rate in Europe (2019-2030) & (L)
  • Figure 13. Latex Particle for In-Vitro Diagnostics Production Growth Rate in China (2019-2030) & (L)
  • Figure 14. Latex Particle for In-Vitro Diagnostics Production Growth Rate in Japan (2019-2030) & (L)
  • Figure 15. Global Latex Particle for In-Vitro Diagnostics Revenue, (US$ Million), 2019 VS 2023 VS 2030
  • Figure 16. Global Latex Particle for In-Vitro Diagnostics Revenue (2019-2030) & (US$ Million)
  • Figure 17. Global Latex Particle for In-Vitro Diagnostics Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
  • Figure 18. Global Latex Particle for In-Vitro Diagnostics Revenue Market Share by Region in Percentage: 2023 Versus 2030
  • Figure 19. Global Latex Particle for In-Vitro Diagnostics Sales (2019-2030) & (L)
  • Figure 20. Global Latex Particle for In-Vitro Diagnostics Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (L)
  • Figure 21. US & Canada Latex Particle for In-Vitro Diagnostics Sales YoY (2019-2030) & (L)
  • Figure 22. US & Canada Latex Particle for In-Vitro Diagnostics Revenue YoY (2019-2030) & (US$ Million)
  • Figure 23. Europe Latex Particle for In-Vitro Diagnostics Sales YoY (2019-2030) & (L)
  • Figure 24. Europe Latex Particle for In-Vitro Diagnostics Revenue YoY (2019-2030) & (US$ Million)
  • Figure 25. China Latex Particle for In-Vitro Diagnostics Sales YoY (2019-2030) & (L)
  • Figure 26. China Latex Particle for In-Vitro Diagnostics Revenue YoY (2019-2030) & (US$ Million)
  • Figure 27. Asia (excluding China) Latex Particle for In-Vitro Diagnostics Sales YoY (2019-2030) & (L)
  • Figure 28. Asia (excluding China) Latex Particle for In-Vitro Diagnostics Revenue YoY (2019-2030) & (US$ Million)
  • Figure 29. Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Sales YoY (2019-2030) & (L)
  • Figure 30. Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Revenue YoY (2019-2030) & (US$ Million)
  • Figure 31. Global Latex Particle for In-Vitro Diagnostics Sales Share by Manufacturers (2023)
  • Figure 32. The Latex Particle for In-Vitro Diagnostics Market Share of Top 3 and Top 5 Largest Manufacturers Around the World in 2023
  • Figure 33. Global Latex Particle for In-Vitro Diagnostics Revenue Share by Manufacturers (2023)
  • Figure 34. The Top 3 and 10 Largest Manufacturers of Latex Particle for In-Vitro Diagnostics in the World: Market Share by Latex Particle for In-Vitro Diagnostics Revenue in 2023
  • Figure 35. US & Canada Latex Particle for In-Vitro Diagnostics Sales Market Share by Type (2019-2030)
  • Figure 36. US & Canada Latex Particle for In-Vitro Diagnostics Revenue Market Share by Type (2019-2030)
  • Figure 37. US & Canada Latex Particle for In-Vitro Diagnostics Sales Market Share by Application (2019-2030)
  • Figure 38. US & Canada Latex Particle for In-Vitro Diagnostics Revenue Market Share by Application (2019-2030)
  • Figure 39. US & Canada Latex Particle for In-Vitro Diagnostics Revenue Share by Country (2019-2030)
  • Figure 40. US & Canada Latex Particle for In-Vitro Diagnostics Sales Share by Country (2019-2030)
  • Figure 41. US Latex Particle for In-Vitro Diagnostics Revenue (2019-2030) & (US$ Million)
  • Figure 42. Canada Latex Particle for In-Vitro Diagnostics Revenue (2019-2030) & (US$ Million)
  • Figure 43. Europe Latex Particle for In-Vitro Diagnostics Sales Market Share by Type (2019-2030)
  • Figure 44. Europe Latex Particle for In-Vitro Diagnostics Revenue Market Share by Type (2019-2030)
  • Figure 45. Europe Latex Particle for In-Vitro Diagnostics Sales Market Share by Application (2019-2030)
  • Figure 46. Europe Latex Particle for In-Vitro Diagnostics Revenue Market Share by Application (2019-2030)
  • Figure 47. Europe Latex Particle for In-Vitro Diagnostics Sales Share by Country (2019-2030)
  • Figure 48. Europe Latex Particle for In-Vitro Diagnostics Revenue Share by Country (2019-2030)
  • Figure 49. Germany Latex Particle for In-Vitro Diagnostics Revenue (2019-2030) & (US$ Million)
  • Figure 50. France Latex Particle for In-Vitro Diagnostics Revenue (2019-2030) & (US$ Million)
  • Figure 51. U.K. Latex Particle for In-Vitro Diagnostics Revenue (2019-2030) & (US$ Million)
  • Figure 52. Italy Latex Particle for In-Vitro Diagnostics Revenue (2019-2030) & (US$ Million)
  • Figure 53. Russia Latex Particle for In-Vitro Diagnostics Revenue (2019-2030) & (US$ Million)
  • Figure 54. China Latex Particle for In-Vitro Diagnostics Sales Market Share by Type (2019-2030)
  • Figure 55. China Latex Particle for In-Vitro Diagnostics Revenue Market Share by Type (2019-2030)
  • Figure 56. China Latex Particle for In-Vitro Diagnostics Sales Market Share by Application (2019-2030)
  • Figure 57. China Latex Particle for In-Vitro Diagnostics Revenue Market Share by Application (2019-2030)
  • Figure 58. Asia Latex Particle for In-Vitro Diagnostics Sales Market Share by Type (2019-2030)
  • Figure 59. Asia Latex Particle for In-Vitro Diagnostics Revenue Market Share by Type (2019-2030)
  • Figure 60. Asia Latex Particle for In-Vitro Diagnostics Sales Market Share by Application (2019-2030)
  • Figure 61. Asia Latex Particle for In-Vitro Diagnostics Revenue Market Share by Application (2019-2030)
  • Figure 62. Asia Latex Particle for In-Vitro Diagnostics Revenue Share by Region (2019-2030)
  • Figure 63. Asia Latex Particle for In-Vitro Diagnostics Sales Share by Region (2019-2030)
  • Figure 64. Japan Latex Particle for In-Vitro Diagnostics Revenue (2019-2030) & (US$ Million)
  • Figure 65. South Korea Latex Particle for In-Vitro Diagnostics Revenue (2019-2030) & (US$ Million)
  • Figure 66. China Taiwan Latex Particle for In-Vitro Diagnostics Revenue (2019-2030) & (US$ Million)
  • Figure 67. Southeast Asia Latex Particle for In-Vitro Diagnostics Revenue (2019-2030) & (US$ Million)
  • Figure 68. India Latex Particle for In-Vitro Diagnostics Revenue (2019-2030) & (US$ Million)
  • Figure 69. Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Sales Market Share by Type (2019-2030)
  • Figure 70. Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Revenue Market Share by Type (2019-2030)
  • Figure 71. Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Sales Market Share by Application (2019-2030)
  • Figure 72. Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Revenue Market Share by Application (2019-2030)
  • Figure 73. Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Revenue Share by Country (2019-2030)
  • Figure 74. Middle East, Africa and Latin America Latex Particle for In-Vitro Diagnostics Sales Share by Country (2019-2030)
  • Figure 75. Brazil Latex Particle for In-Vitro Diagnostics Revenue (2019-2030) & (US$ Million)
  • Figure 76. Mexico Latex Particle for In-Vitro Diagnostics Revenue (2019-2030) & (US$ Million)
  • Figure 77. Turkey Latex Particle for In-Vitro Diagnostics Revenue (2019-2030) & (US$ Million)
  • Figure 78. GCC Countries Latex Particle for In-Vitro Diagnostics Revenue (2019-2030) & (US$ Million)
  • Figure 79. Latex Particle for In-Vitro Diagnostics Value Chain
  • Figure 80. Latex Particle for In-Vitro Diagnostics Production Process
  • Figure 81. Bottom-up and Top-down Approaches for This Report
  • Figure 82. Data Triangulation
  • Figure 83. Key Executives Interviewed